Intrinsic Value

4R0 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The intrinsic value of Oxford Nanopore Technologies PLC (4R0) under the Base Case is 1.61 EUR per share. Compared with the current market price of 2.334 EUR, the stock appears Overvalued by 31% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

4R0 Intrinsic Value
€1.61
Overvaluation 31%
Intrinsic Value
Price €2.334
Alert me when 4R0 is below its intrinsic value
Today €1.288 · 44.8% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to 4R0

Fundamental Analysis

What Oxford Nanopore Technologies Does

Life Sciences Tools & Services Health Care

Oxford Nanopore Technologies makes DNA and RNA sequencing systems that let customers read genetic material by passing it through tiny nanopores. Its products include handheld and lab-based sequencers, sample prep kits, flow cells, and analysis software. The company sells these tools to research labs, hospitals, universities, biotech firms, and government agencies that need fast genetic data.

Headquarters
United Kingdom UK
Employees
1 335
IPO date
Sep 30, 2021
Read the full company overview
View Company Overview

Oxford Nanopore Technologies has no economic moat

No Moat Narrow Wide

Oxford Nanopore Technologies PLC lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue 4R0 Research

Decided on Oxford Nanopore Technologies? Get an email when 4R0 reaches the price you’d buy at. Free with an account.

Other Oxford Nanopore Technologies listings

What is the Intrinsic Value of one 4R0 stock?

The intrinsic value for Oxford Nanopore Technologies PLC (4R0) under the Base Case is 1.61 EUR.

Is 4R0 stock undervalued or overvalued?

Compared with the current market price of 2.334 EUR, the stock appears Overvalued by 31% .

How reliable are our estimates? See how past valuations played out
Back to Top